|Bid||86.15 x 100|
|Ask||92.87 x 100|
|Day's Range||88.81 - 90.73|
|52 Week Range||73.45 - 102.49|
|PE Ratio (TTM)||-26.96|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
A deal with Pfizer, coupled with some likely short-seller covering, has shares headed higher for the second day in a row.
Kite's (KITE) shares were hit by news regarding a patient death resulting from cerebral edema.
It was a solid first quarter from the orphan-drug expert.